Benefytt Technologies Financials

Benefytt Technologies Stock Summary

Benefytt Technologies competes with Where Food, SunOpta, Marfrig Global, Lifevantage, and Bausch Lomb. Benefytt Technologies, Inc., a health insurance technology company, primarily engages in the development and operation of private e-commerce health insurance marketplaces, consumer engagement platforms, agency technology systems, and insurance policy administration platforms. The company was formerly known as Health Insurance Innovations, Inc. and changed its name to Benefytt Technologies, Inc. in March 2020. Health Insurance operates under Health Care Plans classification in USA and is traded on NASDAQ General Markets. It employs 342 people.

Benefytt Technologies Key Financial Ratios

Generally speaking, Benefytt Technologies' financial ratios allow both analysts and investors to convert raw data from Benefytt Technologies' financial statements into concise, actionable information that can be used to evaluate the performance of Benefytt Technologies over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Benefytt Technologies reports annually and quarterly.

Benefytt Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Benefytt Technologies's current stock value. Our valuation model uses many indicators to compare Benefytt Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Benefytt Technologies competition to find correlations between indicators driving Benefytt Technologies's intrinsic value. More Info.Benefytt Technologies is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about  0.19  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Benefytt Technologies is roughly  5.25 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Benefytt Technologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Benefytt Technologies' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Benefytt Technologies' earnings, one of the primary drivers of an investment's value.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

If you are still planning to invest in Benefytt Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Benefytt Technologies' history and understand the potential risks before investing.